Sustained decline in cases of rotavirus gastroenteritis presenting to the children's hospital of Philadelphia in the new rotavirus vaccine era

Pediatric Infectious Disease Journal

Volumn 29, Issue 8, 2010, Pages 699-702

  Clark, H Fred ^a   Lawley, Diane ^a   Matthijnssens, Jelle ^b   Dinubile, Mark J ^c   Hodinka, Richard L ^a  

^a CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^b REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

^c MERCK RESEARCH LABORATORIES   (United States)

Author keywords

gastroenteritis; rotavirus; rotavirus vaccines

Indexed keywords

ROTAVIRUS VACCINE; VIRUS ANTIGEN;

ACUTE GASTROENTERITIS; AGE DISTRIBUTION; ARTICLE; CHILD; DRUG EFFICACY; ENZYME LINKED IMMUNOSORBENT ASSAY; EPIDEMIC; FECES ANALYSIS; HUMAN; INFANT; MAJOR CLINICAL STUDY; NEWBORN; PATIENT MONITORING; PRESCHOOL CHILD; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ROTAVIRUS INFECTION; SEASON; SEROTYPING; UNITED STATES; VACCINATION; VIRAL GASTROENTERITIS; VIRUS TYPING; COMMUNITY-ACQUIRED INFECTIONS; FECES; FEMALE; GASTROENTERITIS; HOSPITAL; IMMUNOLOGY; INCIDENCE; ISOLATION AND PURIFICATION; MALE; ROTAVIRUS; ROTAVIRUS INFECTIONS; VIROLOGY;

ANTIGENS, VIRAL; CHILD, PRESCHOOL; COMMUNITY-ACQUIRED INFECTIONS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FECES; FEMALE; GASTROENTERITIS; HOSPITALS, PEDIATRIC; HUMANS; INCIDENCE; INFANT; MALE; PHILADELPHIA; ROTAVIRUS; ROTAVIRUS INFECTIONS; ROTAVIRUS VACCINES;

EID: 77955157986     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0b013e3181d73524     Document Type: Article

References (30)

1. Centers for Disease Control. Prevention of rotavirus gastroenteritis among infants and children. Morb Mortal Wkly Rep. 2006;55:1-13.
2. Clark HF, Lawley DA, Schaffer A, et al. Assessment of the epidemic potential of a new strain of rotavirus associated with the novel G9 serotype which caused an outbreak in the United States for the first time in the 1995-1996 season. J Clin Microbiol. 2004;42:1434-1438.
3. Vesikari T, Matson DO, Dennehy P, et al. Safety and efficacy of pentavalent human-bovine (WC3) reassortant rotavirus vaccine in preventing rotavirus gastroenteritis and reducing associated healthcare resource utilization. N Engl J Med. 2006;354:23-33.
4. Ruiz-Palacios GM, Perez-Schael I, Velazquez FR, et al. Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. N Engl J Med. 2006;354:11-22.
5. Centers for Disease Control. Delayed onset and diminished magnitude of rotavirus activity-United States, November 2007-May 2008. Morb Mortal Wkly Rep. 2008;57:697-700.
6. Centers for Disease Control. Rotavirus vaccination coverage and adherence to the advisory committee on immunization practices (ACIP)-recommended vaccination schedule-United States, February 2006-May 2007. Morb Mortal Wkly Rep. 2008;57:398-401.
7. Clark HF, Lawley DA, Mallette LA, et al. Decline in cases of rotavirus gastroenteritis presenting to the Children's Hospital of Philadelphia after introduction of a pentavalent rotavirus vaccine. Clin Vaccine Immunol. 2009;16:382-386.
8. Cortese MM, Tate JE, Simonsen L, et al. Reduction in gastroenteritis in US children and correlation with rotavirus vaccine uptake from a national medical claims database. Poster presented at: Programs and abstracts of the Conference on Vaccines for Enteric Diseases, Benalmadina; 2009; Malaga, Spain. Poster 128.
9. Daskalaki I, Spain CV, Long SS, et al. Implementation of rotavirus immunization in Philadelphia, Pennsylvania: high levels of vaccine ineligibility and off-label use. Pediatrics. 2008;122:e33-e38.
10. Daskalaki I, Wood WJ, Inumerable Y, et al. Epidemiology of rotavirusassociated hospitalizations pre and post implementation of immunization: North Philadelphia, 2000-2008. In: Programs and abstracts of the 48th Annual ICAAC/IDSA 46th Annual Meeting; 2008; Washington, DC. Abstract G1-G432.
11. Harrison CJ, Jackson MA, Olson-Burgess C, et al. Fewer 2008 hospitalizations for rotavirus (RV) in Kansas City, two years post RV vaccine. In: Programs and abstracts of the 48th Annual ICAAC/IDSA 46th Annual Meeting; 2008; Washington, DC. Abstract G1-G435.
12. Hatch S, Fontecchio S, Gibson L, et al. Rapid decline in pediatric rotavirus cases following introduction of rotavirus vaccine. In: Programs and abstracts of the 48th Annual ICAAC/IDSA 46th Annual Meeting; 2008; Washington, DC. Abstract G1-G436.
13. Lieberman JM, Huang X, Koski E, et al. Decline in rotavirus cases in the U.S. after licensure of a live, oral rotavirus vaccine. In: Programs and abstracts of the 48th Annual ICAAC/IDSA 46th Annual Meeting; 2008; Washington, DC. Abstract G1-G437.
14. Patel JA, Loeffelhoz M. Reduction of severe rotavirus gastroenteritis following the routine use of live, oral, pentavalent rotavirus vaccine. In: Programs and abstracts of the 48th Annual ICAAC/IDSA 46th Annual Meeting; 2008; Washington, DC. Abstract G1-G434.
15. DiStefano D, Kraiochkine N, Mallette L, et al. Novel rotavirus VP7 typing assay using a one-step reverse transcriptase PCR protocol and product sequencing and utility of the assay for epidemiological studies and strain characterization, including serotype subgroup analysis. J Clin Microbiol. 2005;43:5876-5880.
16. Anderson EJ, Rupp A, Shulman ST, et al. Impact of vaccination on nosocomial transmission of rotavirus. Poster presented at: 47th Annual Meeting of the Infectious Disease Society of America; 2009; Philadelphia, PA. Poster 1149.
17. Cortese M, Tate J, Simonsen L, et al. Reduction in gastroenteritis in children and correlation with rotavirus vaccine uptake from a national medical claims database. Poster presented at: 47th Annual Meeting of the Infectious Disease Society of America; 2009; Philadelphia, PA. Poster 1153.
18. Daskalaki I, Wood SJ, Inumerable Y, et al. No further reduction in rotavirus-associated hospitalizations in north Philadelphia after universal immunization of a second birth cohort. Poster presented at: 47th Annual Meeting of the Infectious Disease Society of America; 2009; Philadelphia, PA. Poster 1154.
19. Harrison CJ, Jackson MA, Olson-Burgess C, et al. Rebound in rotavirus (RV) hospitalizations during 2009 in Kansas City from record low in 2008. Poster presented at: 47th Annual Meeting of the Infectious Disease Society of America; 2009; Philadelphia, PA. Poster 1155.
20. Desai SN, Shapiro ED, Dennehy PH, et al. Effectiveness of rotavirus vaccine in preventing hospitalization of young children. Poster presented at: 47th Annual Meeting of the Infectious Disease Society of America; 2009; Philadelphia, PA. Poster 1152.
21. Herrera Guerra AA, Pavia AT, Thorell EA, et al. Impact of rotavirus vaccination in two Utah hospitals. Poster presented at: 47th Annual IDSA; 2009; Philadelphia, PA. Poster 1150.
22. Rahman M, Matthijnssens J, Goegebuer T, et al. Predominance of rotavirus G9 genotype in children hospitalized for rotavirus gastroenteritis in Belgium during 1999-2003. J Clin Virol. 2005;33:1-6.
23. Iturriza-Gomara M, Dallman T, Banyai K, et al. Rotavirus surveillance in Europe, 2005-2009: web-enabled reporting and real-time analysis of genotyping and epidemiological data. J Infect Dis. 2009;200(suppl):S215-S221.
24. Abdel-Haq NM, McGrath E, Chearskul P, et al. Emergence of rotavirus (RV) G9 genotype in Detroit: implications on vaccine programs. Poster presented at: 47th Annual Meeting of the Infectious Disease Society of America; 2009; Philadelphia, PA. Poster 1152.
25. Rodrigues F, Iturriza M, Marinho J, et al. Incidence and fluctuation of rotavirus (RV) genotypes before and after launch of rotavirus vaccines in Portugal. Poster presented at: 47th Annual Meeting of the Infectious Disease Society of America; 2009; Philadelphia, PA. Poster 1151.
26. Sanzone AM, Begue RE. Significant change in rotavirus genotypes in the era of vaccination. Poster presented at: 47th Annual Meeting of the Infectious Disease Society of America; 2009; Philadelphia, PA. Poster 1156.
27. Matthijnssens J, Bilcke J, Ciarlet M, et al. Rotavirus disease and vaccination: impact on genotype diversity. Future Microbiol. 2009;4:1303-1316.
28. Aupiais C, de Rougemont A, Menager C, et al. Severity of acute gastroenteritis in infants infected by G1 or G9 rotaviruses. J Clin Virol. 2009;46: 282-285.
29. Parashar UD, Hummelman EG, Bresee JS, et al. Global illness and deaths caused by rotavirus disease in children. Emerg Infect Dis. 2003;9:565-572.
30. Patel M, Pedreira C, De Oliveira LH, et al. Association between pentavalent rotavirus vaccine and severe rotavirus diarrhea among children in Nicaragua. JAMA. 2009;301:2243-2251.